Headlines & Research Highlights
Building on nearly 20 years of scientific collaboration, McMaster joins the ranks of full member university partners at TRIUMF.
Speaking at the 11th International Symposium on Targeted Alpha Therapy (TAT 11) in Ottawa, the organizations announced today a new partnership that brings together their respective R&D, manufacturing, and commercialization strengths to develop innovative, personalized cancer treatments.
An international collaboration, including several members from TRIUMF’s Theory Department, today published results that may dispel a long-standing mystery surrounding β-decay rates.
As we round the corner on TRIUMF’s 50th birthday, we also look back at one of its most important and enduring relationships and a team who has stewarded a critical contribution to the lab’s growth and success for over four decades.
The laboratory’s inaugural peer recognition awards highlighted ingenuity, safety, and community-building.